Phenotypic polymorphism of haptoglobin: A novel risk factor for the development of infection in liver cirrhosis

Zsuzsanna Vitalis, I. Altorjay, Istvan Tornai, K. Palatka, Sandor Kacska, Eszter Palyu, David Tornai, M. Udvardy, J. Hársfalvi, Tamas Dinya, G. Verès, P. Lakatos, M. Papp

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The α-chain alleles 1 and 2 of haptoglobin (Hp) molecule account for three phenotypes, which have biologically important differences in their antioxidant, scavenging, and immunomodulatory properties and may thereby influence the course of inflammatory diseases. A follow-up observational study was conducted to assess the association between haptoglobin phenotype and the development of clinically significant bacterial infections in patients with liver cirrhosis. Sera of 336 patients with liver cirrhosis of various etiologies and 384 healthy subjects were investigated. Haptoglobin phenotypes were determined by gel electrophoresis and assigned corresponding genotype. Haptoglobin phenotype distributions of patients and controls was similar (Hp. 1-1: 10.7% vs 11.5%, Hp. 2-1: 47.9% vs 46.1% and Hp. 2-2: 41.4% vs 42.4%). The probability of clinically significant bacterial infections was calculated for each haptoglobin phenotype (Hp. 1-1: 50.0%, Hp. 2-1: 36.0% and Hp. 2-2: 26.6%, p = 0.039). In a logistic regression analysis, Hp. 1-1 phenotype (p = 0.015, OR: 2.74, 95% CI: 1.22-6.13), Child-Pugh stage (p = 0.038, OR: 1.40, 95% CI: 1.02-1.91) and presence of co-morbidities (p <0.001, OR: 2.64, 95% CI: 1.63-4.27) were independently associated with infections. In a Cox regression analysis, Hp. 1-1 phenotype (p = 0.014), Child-Pugh stage C (p <0.001), and presence of co-morbidities (p = 0.004) were associated with time to first infectious episode. Phenotypic haptoglobin polymorphism was independent predictor for risk and time to first clinically significant bacterial infectious episode.

Original languageEnglish
Pages (from-to)348-354
Number of pages7
JournalHuman Immunology
Volume72
Issue number4
DOIs
Publication statusPublished - Apr 2011

Fingerprint

Haptoglobins
Liver Cirrhosis
Infection
Phenotype
Bacterial Infections
Regression Analysis
Morbidity
Observational Studies
Electrophoresis

Keywords

  • Bacterial infection
  • Haptoglobin polymorphism
  • Liver cirrhosis

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Phenotypic polymorphism of haptoglobin : A novel risk factor for the development of infection in liver cirrhosis. / Vitalis, Zsuzsanna; Altorjay, I.; Tornai, Istvan; Palatka, K.; Kacska, Sandor; Palyu, Eszter; Tornai, David; Udvardy, M.; Hársfalvi, J.; Dinya, Tamas; Verès, G.; Lakatos, P.; Papp, M.

In: Human Immunology, Vol. 72, No. 4, 04.2011, p. 348-354.

Research output: Contribution to journalArticle

@article{77794376566241e481b2be7739749092,
title = "Phenotypic polymorphism of haptoglobin: A novel risk factor for the development of infection in liver cirrhosis",
abstract = "The α-chain alleles 1 and 2 of haptoglobin (Hp) molecule account for three phenotypes, which have biologically important differences in their antioxidant, scavenging, and immunomodulatory properties and may thereby influence the course of inflammatory diseases. A follow-up observational study was conducted to assess the association between haptoglobin phenotype and the development of clinically significant bacterial infections in patients with liver cirrhosis. Sera of 336 patients with liver cirrhosis of various etiologies and 384 healthy subjects were investigated. Haptoglobin phenotypes were determined by gel electrophoresis and assigned corresponding genotype. Haptoglobin phenotype distributions of patients and controls was similar (Hp. 1-1: 10.7{\%} vs 11.5{\%}, Hp. 2-1: 47.9{\%} vs 46.1{\%} and Hp. 2-2: 41.4{\%} vs 42.4{\%}). The probability of clinically significant bacterial infections was calculated for each haptoglobin phenotype (Hp. 1-1: 50.0{\%}, Hp. 2-1: 36.0{\%} and Hp. 2-2: 26.6{\%}, p = 0.039). In a logistic regression analysis, Hp. 1-1 phenotype (p = 0.015, OR: 2.74, 95{\%} CI: 1.22-6.13), Child-Pugh stage (p = 0.038, OR: 1.40, 95{\%} CI: 1.02-1.91) and presence of co-morbidities (p <0.001, OR: 2.64, 95{\%} CI: 1.63-4.27) were independently associated with infections. In a Cox regression analysis, Hp. 1-1 phenotype (p = 0.014), Child-Pugh stage C (p <0.001), and presence of co-morbidities (p = 0.004) were associated with time to first infectious episode. Phenotypic haptoglobin polymorphism was independent predictor for risk and time to first clinically significant bacterial infectious episode.",
keywords = "Bacterial infection, Haptoglobin polymorphism, Liver cirrhosis",
author = "Zsuzsanna Vitalis and I. Altorjay and Istvan Tornai and K. Palatka and Sandor Kacska and Eszter Palyu and David Tornai and M. Udvardy and J. H{\'a}rsfalvi and Tamas Dinya and G. Ver{\`e}s and P. Lakatos and M. Papp",
year = "2011",
month = "4",
doi = "10.1016/j.humimm.2011.01.008",
language = "English",
volume = "72",
pages = "348--354",
journal = "Human Immunology",
issn = "0198-8859",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Phenotypic polymorphism of haptoglobin

T2 - A novel risk factor for the development of infection in liver cirrhosis

AU - Vitalis, Zsuzsanna

AU - Altorjay, I.

AU - Tornai, Istvan

AU - Palatka, K.

AU - Kacska, Sandor

AU - Palyu, Eszter

AU - Tornai, David

AU - Udvardy, M.

AU - Hársfalvi, J.

AU - Dinya, Tamas

AU - Verès, G.

AU - Lakatos, P.

AU - Papp, M.

PY - 2011/4

Y1 - 2011/4

N2 - The α-chain alleles 1 and 2 of haptoglobin (Hp) molecule account for three phenotypes, which have biologically important differences in their antioxidant, scavenging, and immunomodulatory properties and may thereby influence the course of inflammatory diseases. A follow-up observational study was conducted to assess the association between haptoglobin phenotype and the development of clinically significant bacterial infections in patients with liver cirrhosis. Sera of 336 patients with liver cirrhosis of various etiologies and 384 healthy subjects were investigated. Haptoglobin phenotypes were determined by gel electrophoresis and assigned corresponding genotype. Haptoglobin phenotype distributions of patients and controls was similar (Hp. 1-1: 10.7% vs 11.5%, Hp. 2-1: 47.9% vs 46.1% and Hp. 2-2: 41.4% vs 42.4%). The probability of clinically significant bacterial infections was calculated for each haptoglobin phenotype (Hp. 1-1: 50.0%, Hp. 2-1: 36.0% and Hp. 2-2: 26.6%, p = 0.039). In a logistic regression analysis, Hp. 1-1 phenotype (p = 0.015, OR: 2.74, 95% CI: 1.22-6.13), Child-Pugh stage (p = 0.038, OR: 1.40, 95% CI: 1.02-1.91) and presence of co-morbidities (p <0.001, OR: 2.64, 95% CI: 1.63-4.27) were independently associated with infections. In a Cox regression analysis, Hp. 1-1 phenotype (p = 0.014), Child-Pugh stage C (p <0.001), and presence of co-morbidities (p = 0.004) were associated with time to first infectious episode. Phenotypic haptoglobin polymorphism was independent predictor for risk and time to first clinically significant bacterial infectious episode.

AB - The α-chain alleles 1 and 2 of haptoglobin (Hp) molecule account for three phenotypes, which have biologically important differences in their antioxidant, scavenging, and immunomodulatory properties and may thereby influence the course of inflammatory diseases. A follow-up observational study was conducted to assess the association between haptoglobin phenotype and the development of clinically significant bacterial infections in patients with liver cirrhosis. Sera of 336 patients with liver cirrhosis of various etiologies and 384 healthy subjects were investigated. Haptoglobin phenotypes were determined by gel electrophoresis and assigned corresponding genotype. Haptoglobin phenotype distributions of patients and controls was similar (Hp. 1-1: 10.7% vs 11.5%, Hp. 2-1: 47.9% vs 46.1% and Hp. 2-2: 41.4% vs 42.4%). The probability of clinically significant bacterial infections was calculated for each haptoglobin phenotype (Hp. 1-1: 50.0%, Hp. 2-1: 36.0% and Hp. 2-2: 26.6%, p = 0.039). In a logistic regression analysis, Hp. 1-1 phenotype (p = 0.015, OR: 2.74, 95% CI: 1.22-6.13), Child-Pugh stage (p = 0.038, OR: 1.40, 95% CI: 1.02-1.91) and presence of co-morbidities (p <0.001, OR: 2.64, 95% CI: 1.63-4.27) were independently associated with infections. In a Cox regression analysis, Hp. 1-1 phenotype (p = 0.014), Child-Pugh stage C (p <0.001), and presence of co-morbidities (p = 0.004) were associated with time to first infectious episode. Phenotypic haptoglobin polymorphism was independent predictor for risk and time to first clinically significant bacterial infectious episode.

KW - Bacterial infection

KW - Haptoglobin polymorphism

KW - Liver cirrhosis

UR - http://www.scopus.com/inward/record.url?scp=79952620387&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952620387&partnerID=8YFLogxK

U2 - 10.1016/j.humimm.2011.01.008

DO - 10.1016/j.humimm.2011.01.008

M3 - Article

C2 - 21262313

AN - SCOPUS:79952620387

VL - 72

SP - 348

EP - 354

JO - Human Immunology

JF - Human Immunology

SN - 0198-8859

IS - 4

ER -